MedPath

Effect of probiotics on patients with type 2 diabetes

Not Applicable
Conditions
Type 2 Diabetes.
Non-insulin-dependent diabetes mellitus
Registration Number
IRCT201109197598N1
Lead Sponsor
Researches and Technology Deputy of Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Inclusion Criteria:
Patients with diabetes type 2 were enrolled with FBS = 126 mgr / dl ; less than 15 years of their disease were over ; the age range was 25 to 65 years ; Elective subjects, next drugs prescribed by doctors, should be controlled the status of glucose and lipid levels and during the study could use of these drugs without changing in the prior dosage.

Exclusion Criteria

Patients with diabetes type 2 that used replace treatments like Hormone or supplemental vitamin ; Also those used tobacco and alcohol ; patients with chronic kidney disease ; liver ; lung ; chronic or acute inflammatory disease (especially acute pancreatic inflammation and Endocarditis) ; heart valve disease ; short bowel syndrome ; allergies ; people with low immune system ability (autoimmune) ; pregnant or lactating women.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ipid Profile ( Tg,Total Chol, LDL-C, HDL-C ). Timepoint: Before and After Intervention. Method of measurement: Autoanalyzer.;Serum Glucose. Timepoint: Before and after Intervention. Method of measurement: Autoanalyzer.;Serum Insulin Levels. Timepoint: Before and After Intervention. Method of measurement: ELISA.;Hs-CRP. Timepoint: Before and after intervention. Method of measurement: ELISA.;IL-6. Timepoint: Before and After Intervention. Method of measurement: Autoanalyzer.;Malodialdehyde (MDA). Timepoint: Before and after Intervention. Method of measurement: Specterophotometery.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath